What does it cost to miss a deadline? For the company that makes the prescription painkiller Oxycontin, the answer could be more than $1 billion.
Dow Chemical is breaking off a significant portion of its chlorine operations in a deal valued...
In uncommon bipartisan harmony, the House approved a $214 billion bill on Thursday permanently...
Genentech, a member of the Roche Group, has announced plans to invest more than $125 million for...
The Board of Directors of Sagent Pharmaceuticals has announced that Jeffrey Yordon, Chairman and Chief Executive Officer, has informed the Board of his decision to retire from the company.
Current developments in the biopharmaceutical industry have added significantly to the challenges of designing, building, and operating biopharmaceutical manufacturing facilities.
Recipharm AB and Adroit Science AB have announced the formation of a new strategic collaboration. Adroit Science AB will support Recipharm’s pharmaceutical development with high quality solid state characterization services
The impact of work-in-process (WIP) on oral solid dosage (OSD) plant design
A new report expects the market value for sepsis treatments to increase more than thirteen-fold between 2016 and 2021 following the launch of a new sepsis-specific drug.
Federal officials plan to review the safety and evidence behind alternative remedies like Zicam and Cold-Eeze, products that are protected by federal law, but not accepted by mainstream medicine.
Orexigen Therapeutics has announced that the European Commission has granted marketing authorization for Mysimba (naltrexone HCl / bupropion HCl prolonged release) as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients.
The goal of the collaboration is to discover and develop novel therapies to treat rare diseases with high unmet medical need combining Shire's development and commercialization capabilities with Cincinnati Children's research expertise.
AstraZeneca today announced that it has joined a public-private consortium with Genomics England to accelerate the development of new diagnostics and treatments arising from the 100,000 Genomes Project.
Capsugel has announced that the company is investing more than $25 million to increase production capacity and deliver further quality enhancements for its vegetarian capsules.
British Prime Minister David Cameron on Wednesday apologized to thousands of patients who were infected from contaminated blood during the 1970s and 1980s.
Defining categories for potency of pharmaceutical compounds has been invaluable to our industry. It allows R&D to evaluate and define the potency of new compounds so they may be handled safely.
Manually executed cleaning techniques and procedures have been utilized to wash small change parts and equipment since the inception of oral solid dosage manufacturing.
Texas prison officials have acquired a small supply of pentobarbital to replenish their dwindling inventory of the execution drug so lethal injections set for next month can be carried out.
The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits.